Dianthus Therapeutics Stock Performance
as on August 29, 2026 at 2:16 pm IST
Day's Low
Day's High
$105.76$111.28
0.08%
Downside
5.14%
Upside
52 Week's Low
52 Week's High
$22.81$117.8878.45%
Downside
11.37%
Upside
Dianthus Therapeutics share price movements today
- Previous Close
- $111.54
- Open
- $111.28
- Volume
- 275.1K
- Market Cap
- $6.2B
- Day's Low - High
- $105.76 - $111.28
- 52 Week Low - High
- $22.81 - $117.88
Dianthus Therapeutics Historical Returns
- 1 Month Return
- + 9.77 %
- 3 Month Return
- + 22.76 %
- 1 Year Return
- + 349.58 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Dianthus Therapeutics Stock Fundamentals & Key Indicators
Check Dianthus Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.2B
EPS (TTM)
-0.13
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-843.08
Industry PE ratio
-12.87
PEG Ratio
139.18152866241982
EBITDA
-29.5M
Revenue (TTM)
1.9M
Profit Margin
96.01%
Return On Equity TTM
-3.51%
Dianthus Therapeutics Stock Valuation
Track how Dianthus Therapeutics P/E has moved over time to understand its valuation trends.
Dianthus Therapeutics in the last 5 years
Lowest (-18.57x)
December 31, 2021
Industry (-12.87x)
December 31, 2025
Today (-9.81x)
December 31, 2025
Highest (-0.83x)
December 31, 2022
Today’s Price to Earnings Ratio: -9.81x
Dianthus Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dianthus Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $6.2B | NA | -843.08 | 96.01% | NA | |
| BUY | $46.2B | 675.69% | NA | 0.00% | NA | |
| BUY | $138.7B | 173.88% | 31.92 | 86.04% | NA | |
| BUY | $59.7B | -62.65% | -7.98 | -12.57% | NA | |
| BUY | $85.8B | 21.77% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Dianthus Therapeutics Stock including INR - Dollar returns
The Dianthus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Dianthus Therapeutics investment value today
Current value as on today
₹4,61,466
Returns
₹3,61,466
(+361.47%)
Returns from Dianthus Therapeutics Stock
₹3,26,602 (+326.6%)
Dollar Impact
₹34,864 (+34.86%)
Analyst Recommendation on Dianthus Therapeutics Stock
Based on 13 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 13 analysts, 100% of analysts recommend a 'BUY' rating for Dianthus Therapeutics. Average target price of $137.62
Dianthus Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Dianthus Therapeutics.
What analysts predicted
23.09%UPSIDE
Target Price
$137.62
Current Price
$105.84
Analyzed by
13 Analysts
Target
$137.62
Dianthus Therapeutics target price $137.62, a slight upside of 23.09% compared to current price of $105.84. According to 13 analysts rating.
Indian Investors' Interest in Dianthus Therapeutics Stock
Search interest for Dianthus Therapeutics Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Dianthus Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Dianthus Therapeutics Annual Profit & Loss
All numbers in Millions USD
Dianthus Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Dianthus Therapeutics Annual Cash Flow
All numbers in Millions USD
Dianthus Therapeutics News & Key Events
Today's Timeline - 12 June
Sat, 02:43 AM
-Dianthus reports 75% improvement in CIDP trial, exceeding expectations, leading to an 8% stock increase.
Insights on Dianthus Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 284.0K → 761.0K (in $), with an average increase of 38.9% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, DNTH stock has moved up by 91.8%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DNTH has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 123.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 97.90M → -50.21M (in $), with an average decrease of 82.3% per quarter
About Dianthus Therapeutics
| Organisation | Dianthus Therapeutics |
| Headquarters | 7 Times Square, New York, NY, United States, 10036 |
| Industry | Biotechnology |
| CEO | Mr. Marino Garcia M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Dianthus Therapeutics
Name | Title |
|---|---|
Ms. Kristina Maximenko | Chief People Officer |
Mr. Marino Garcia M.B.A. | President, CEO & Director |
Mr. Ryan Savitz | Executive VP, CFO, Chief Business Officer & Treasurer |
Dr. Simrat Randhawa M.B.A., M.D. | Executive VP and Head of R&D |
Mr. Adam M. Veness Esq. | Senior VP, General Counsel & Secretary |
Mr. Scott Nogi M.B.A. | Head of Business Operations |
Mr. Edward G. Carr | Senior VP & Chief Accounting Officer |
Mr. Judson Taylor | Senior VP & Head of Technical Operations |
Ms. Jennifer Davis Ruff | VP and Head of Investor Relations & Corporate Affairs |
Ms. Rashieda Gluck | Head of Clinical Development Operations |
FAQs
What is Dianthus Therapeutics share price today?
Dianthus Therapeutics share price today is $105.84 as on at the close of the market. Dianthus Therapeutics share today touched a day high of $111.28 and a low of $105.76.
What is the 52 week high and 52 week low for Dianthus Therapeutics share?
Dianthus Therapeutics share touched a 52 week high of $117.88 on and a 52 week low of $22.81 on . Dianthus Therapeutics stock price today i.e. is closed at $105.84,which is 10.21% down from its 52 week high and 364.01% up from its 52 week low.
What is Dianthus Therapeutics's market capitalisation today?
Dianthus Therapeutics market capitalisation is $0.01T as on .
How to invest in Dianthus Therapeutics Stock (DNTH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Dianthus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dianthus Therapeutics Shares that will get you 0.0142 shares as per Dianthus Therapeutics share price of $105.84 per share as on August 29, 2026 at 8:46 am IST.
What is the minimum amount required to buy Dianthus Therapeutics Stock (DNTH) from India?
Indian investors can start investing in Dianthus Therapeutics (DNTH) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Dianthus Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dianthus Therapeutics share’s latest price of $105.84 as on August 29, 2026 at 8:46 am IST, you will get 0.0945 shares of Dianthus Therapeutics. Learn more about
fractional shares .